Abstract
An increasing prevalence of diabetes and hypertension in the US population has fueled the robust market for self-diagnostic testing kits, especially those that monitor glucose or blood pressure. Demographic factors, a growing self-care trend, insurance coverage and shifting birth and infertility rates have also played a roll in sales for everything from pregnancy tests to ovulation prediction kits to glucose/blood pressure monitors.
Beyond discussion of these driving trends, this report also analyzes:
- How the mail order/direct-to-consumer services impact the FDM retail market
- Which drug stores lead the market and how they combat mail order competition
- Why Johnson & Johnson-owned companies comprise a full quarter of the FDM market, while most other companies have experienced sales declines since 2005
- How older Americans, women and different ethnic groups offer unique marketing opportunities for self-diagnostic testing kit manufacturers
- Who uses self-diagnostics, why and how they feel about it
- How the market will change and develop in coming years
This report builds on the analysis presented in Mintel' s Self-Diagnostics- US, March 2004. The self-diagnostics market is defined as any product, device or test that is used by the consumer to identify or monitor a specific health condition without medical or professional assistance. This includes both chemically based home testing kits and electronic devices.
For the purpose of this report, Mintel has included only the following in its market size:
- Blood glucose monitors
- Blood pressure monitors
- Home pregnancy tests
- Ovulation tests.
Excluded from this report are tests carried out by hospitals, doctors, nurses, pharmacists or other healthcare workers. Also excluded are devices such as scales, which are used solely to measure weight, and other physical measuring devices, such as thermometers.
View Cart
